Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study.
(1) Background: Metastatic L-type sarcomas (liposarcoma and leiomyosarcoma) are rare and have a poor prognosis. Trabectedin is an effective agent that can be used after anthracyclines. This study was designed to evaluate the real-life effectiveness and safety of trabectedin. (2) Methods: A retrospec...
| Publicado en: | Current Oncology Vol. 31; no. 11; pp. 6803 - 6814 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Nov2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |